Deal Library / Pharma BD Deal Intelligence

Sarepta Therapeutics Inc. — Pharma Deals

The Pharma Closeout tracks 6 deals, $1.1B in disclosed deal value, 1 with a post-close Outcome Score for Sarepta Therapeutics Inc..

Median Critic Score: 93  ·  Median Outcome Score: 72

All 6 deals

• Sarepta Therapeutics Inc. / Arrowhead Pharmaceuticals Inc. — 2024 · $1.1B · Largely worked — most objectives met.
• Sarepta Therapeutics Inc. / GenEdit, Inc. — 2022
• Sarepta Therapeutics Inc. / Genevant Sciences — 2021
• Sarepta Therapeutics Inc. / Codiak BioSciences, Inc. — 2020
• Sarepta Therapeutics Inc. / StrideBio, Inc — 2019
• Sarepta Therapeutics Inc. / Myonexus Therapeutics — 2019

← Deal Library  ·  Interactive search  ·  How we score deals